title: Morphologic, hemodynamic and coronary perfusion characteristics in severe left ventricular hypertrophy secondary to systemic hypertension and evidence for nonatherosclerotic myocardial ischemia.
abstract: Patients with the clinical diagnosis of ischemic heart disease who were found to be free of significant coronary artery atherosclerotic disease (n = 150) underwent coronary vasodilator reserve testing, 2-dimensional echocardiography, and dipyridamole limited-stress thallium testing. After exclusions (predominantly for technically poor coronary artery Doppler signals or suboptimal echocardiography), 100 patients formed the study population. The purpose was to characterize typical cardiac and coronary artery findings in hypertensive patients with severe left ventricular (LV) hypertrophy (n = 15) and to investigate the evidence for myocardial ischemia unrelated to coronary atherosclerosis in early and advanced hypertensive heart disease. Normotensive and hypertensive control groups without LV hypertrophy (n = 12 and 34, respectively) were used for comparison. Severe LV hypertrophy was defined as LV mass index greater than or equal to 50% above established gender specific norms using 2-dimensional-directed M-mode echocardiography and the cube equation corrected to agree with necropsy estimates of mass. Clinical characteristics more often associated with severe LV hypertrophy were black race (67%), diabetes mellitus (33%), proteinuria (47%) and elevated creatinine (1.5 +/- 0.9 mg/dl). Baseline electrocardiograms and dipyridamole limited-stress thallium scans were highly likely to be abnormal (94 and 73%, respectively). Both eccentric and concentric cardiac hypertrophies were found in the severe group. Ejection fraction was significantly lower (0.51 vs 0.68, p = 0.002) and basal coronary flow velocity higher (12.0 vs 5.0 cm/s, p = 0.0004) among these patients when compared with normotensive control patients. Coronary flow reserve did not differ between control groups but was significantly depressed in patients with severe LV hypertrophy (2.5 vs 3.9, p = 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Medicine, Medical College of Georgia, Augusta 30912.
authors.forename: J L
authors.initials: JL
authors.lastname: Houghton
authors.forename: A A
authors.initials: AA
authors.lastname: Carr
authors.forename: L M
authors.initials: LM
authors.lastname: Prisant
authors.forename: W B
authors.initials: WB
authors.lastname: Rogers
authors.forename: T W
authors.initials: TW
authors.lastname: von Dohlen
authors.forename: N C
authors.initials: NC
authors.lastname: Flowers
authors.forename: M J
authors.initials: MJ
authors.lastname: Frank
mesh_terms: D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D006332:Cardiomegaly / Q000175:diagnosis / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology*; D003324:Coronary Artery Disease / Q000175:diagnosis; D003326:Coronary Circulation; D003937:Diagnosis, Differential; D004452:Echocardiography; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications*; D008297:Male; D008875:Middle Aged; D013794:Thallium Radioisotopes; D014655:Vascular Resistance
chemical_list: D013794:Thallium Radioisotopes